Ata uhi

QR Code

Market menagerie health and development in late industrial states /

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi matua:	Srinivas, Smita
Kaituhi rangatōpū:	ebrary, Inc
Hōputu:	Tāhiko īPukapuka
Reo:	Ingarihi
I whakaputaina:	Stanford, California : Stanford Economics and Finance, an imprint of Stanford University Press, c2012.
Ngā marau:	Pharmaceutical industry > Government policy > India. Medical policy > India. Health services accessibility > Developing countries. Medical policy > Developing countries. Pharmaceutical industry > Technological innovations > Developing countries. Pharmaceutical industry > Technological innovations > India. Pharmaceutical industry > Government policy > Developing countries. Health services accessibility > India. Electronic books.
Urunga tuihono:	An electronic book accessible through the World Wide Web; click to view
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

The reconfiguration of a latecomer innovation system : governing pharmaceutical biotechnology innovation in South Korea /
mā: Johann, Dirk, 1972-
I whakaputaina: (2013)

Understanding drugs markets : an analysis of medicines, regulations, and pharmaceutical systems in the global south /
I whakaputaina: (2022)

Measuring transparency to improve good governance in the public pharmaceutical sector.
I whakaputaina: (2009)

Measuring transparency to improve good governance in the public pharmaceutical sector.
I whakaputaina: (2009)

Access to medicines and vaccines in the South : coherence of rules and policies applied by the European Union Commission /
mā: Kingah, Stephen
I whakaputaina: (2011)

Innovation in the biopharmaceutical industry
I whakaputaina: (2007)

An investigation of the effect of healthcare policy change on sales and strategies of anti-malarial pharmaceutical companies in Kenya /
mā: Nyaoke, Lorraine M.
I whakaputaina: (2009)

Pharmacy on a bicycle innovative solutions to global health and poverty /
mā: Bing, Eric G.
I whakaputaina: (2013)

Pharmaceutical pricing policies in a global market
I whakaputaina: (2008)

Coherence for health innovation for new medicines for infectious diseases.
I whakaputaina: (2009)

Pharmaceutical reform a guide to improving performance and equity /
mā: Roberts, Marc J.
I whakaputaina: (2011)

Les prix des medicaments sur un marche global politiques et enjeux.
I whakaputaina: (2008)

The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
I whakaputaina: (2006)

Medicines as a service a new commercial model for big pharma in the postblockbuster world /
mā: Mattke, Soeren
I whakaputaina: (2012)

Negotiating health : intellectual property and access to medicines /
I whakaputaina: (2006)

Pharmaceutical economics and policy
mā: Schweitzer, Stuart O.
I whakaputaina: (2007)

South-South collaboration in health biotechnology : growing partnerships amongst developing countries /
I whakaputaina: (2012)

Pharmacogenetics opportunities and challenges for health innovation.
I whakaputaina: (2009)

In sickness and in health : the future of medicine : added value & global access /
I whakaputaina: (2009)

Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
I whakaputaina: (2008)

Battling HIV/AIDS a decision maker's guide to the procurement of medicines and related supplies /
mā: Tayler, Yolanda, 1957-
I whakaputaina: (2004)

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
mā: Cook, Arthur G.
I whakaputaina: (2006)

Pharmaceutical blending and mixing /
I whakaputaina: (2015)

The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)

Building a national framework for the establishment of regulatory science for drug development workshop summary /
I whakaputaina: (2011)

Better health systems for India's poor findings, analysis, and options /
I whakaputaina: (2002)

Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)

A practical approach to pharmaceutical policy
mā: Seiter, Andreas
I whakaputaina: (2010)

Towards drugs of the future key issues in lead finding and lead optimization /
I whakaputaina: (2008)

Improving health service delivery in developing countries from evidence to action /
I whakaputaina: (2009)

Crystallization of organic compounds an industrial perspective /
mā: Tung, Hsien-Hsin, 1955-
I whakaputaina: (2009)

The global opportunity in IT-based services assessing and enhancing country competitiveness /
I whakaputaina: (2010)

Continuous processing in pharmaceutical manufacturing /
I whakaputaina: (2015)

The Changing economics of medical technology
I whakaputaina: (1991)

Drug efficacy, safety, and biologics discovery emerging technologies and tools /
I whakaputaina: (2009)

Glocal pharma : international brands and the imagination of local masculinity /
mā: Johnson, Ericka
I whakaputaina: (2016)

The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
I whakaputaina: (1983)

India's late, late industrial revolution democratizing entrepreneurship /
mā: Majumdar, Sumit Kumar
I whakaputaina: (2012)

Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)

The convergence of science and governance research, health policy, and American states /
mā: Fox, Daniel M.
I whakaputaina: (2010)